Role of Proxy Respondents in International Stroke Research: Experience of the INTERSTROKE Study.


Journal

Neuroepidemiology
ISSN: 1423-0208
Titre abrégé: Neuroepidemiology
Pays: Switzerland
ID NLM: 8218700

Informations de publication

Date de publication:
2022
Historique:
received: 15 04 2022
accepted: 07 06 2022
pubmed: 12 7 2022
medline: 8 11 2022
entrez: 11 7 2022
Statut: ppublish

Résumé

Measuring patient-reported information in stroke research is challenging. To overcome this, use of proxy respondents is often a necessary strategy. In this study, we report on use and effect of proxy respondents on patient case-mix in a large international epidemiologic stroke study (INTERSTROKE). This was a cross-sectional study of 13,458 cases of acute first stroke in 32 countries. A standardized study questionnaire recording behavioural cardiovascular risk factors was administered to the patient, and if unable to communicate adequately, a valid proxy, or both. We used logistic regression to evaluate the association of age, sex, education, occupation, stroke severity, and region with need for proxy respondent, and report odds ratio (OR) with 95% confidence interval (CI). Among 13,458 participants with acute stroke, questionnaires were completed by patients alone in 41.4% (n = 5,573), combination of patient and proxy together in 21.7% (n = 2,918), and proxy alone in 36.9% (n = 4,967). Use of proxy alone was greater in participants with severe stroke (4.7% with modified-Rankin score of 0 vs. 80.5% in those with score 5; OR 187.13; 95% CI: 119.61-308.22), older persons (43.8% of those aged 80 years and over vs. 33.2% of those aged less than 40 years; age per decade OR 1.09; 95% CI: 1.06-1.12), women (40.7% vs. 34.3% of men; OR 1.32 95% CI: 1.22-1.43), and those less educated (58.9% of those never educated vs. 25.7% of those who attended third level education; OR 7.84; 95% CI: 6.78-9.08). Use of proxy respondents enhances the generalizability of international research studies of stroke, by increasing representation of women, patients with severe stroke, older age, and lower education.

Identifiants

pubmed: 35817005
pii: 000525510
doi: 10.1159/000525510
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

355-364

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

© 2022 S. Karger AG, Basel.

Auteurs

Maria M Costello (MM)

HRB-Clinical Research Facility, National University of Ireland Galway, Galway, Ireland.

Conor Judge (C)

HRB-Clinical Research Facility, National University of Ireland Galway, Galway, Ireland.
Translational Medical Device Laboratory, National University of Ireland Galway, Galway, Ireland.
Wellcome Trust - HRB, Irish Clinical Academic Training, Dublin, Ireland.

Catriona Reddin (C)

HRB-Clinical Research Facility, National University of Ireland Galway, Galway, Ireland.
Wellcome Trust - HRB, Irish Clinical Academic Training, Dublin, Ireland.

Sumathy Rangarajan (S)

Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.

Peter Langhorne (P)

Glasgow Royal Infirmary, University of Glasgow, Glasgow, UK.

Hongye Zhang (H)

Beijing Hypertension League Institute, Beijing, China.

Helle K Iversen (HK)

Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Denis Xavier (D)

St John's Medical College and Research Institute, Bangalore, India.

Andrew Smyth (A)

HRB-Clinical Research Facility, National University of Ireland Galway, Galway, Ireland.
Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.

Michelle D Canavan (MD)

HRB-Clinical Research Facility, National University of Ireland Galway, Galway, Ireland.

Salim Yusuf (S)

Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.

Martin J O'Donnell (MJ)

HRB-Clinical Research Facility, National University of Ireland Galway, Galway, Ireland.
Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH